Efficacy and safety of a third SARS-CoV-2 vaccination in multiple sclerosis vaccine non-responders

Marton König, Hilde Marie Torgauten, Mathias Herstad Øverås, Adity Chopra, Åslaug Rudjord Lorentzen, The Trung Tran, Siri Mjaaland, Ingeborg Sundsvalen Aaberge, Kjell-Morten Myhr, Stig Wergeland, Tone Berge, Hanne Flinstad Harbo, Øivind Fredvik Torkildsen, Trygve Holmøy, Elisabeth Gulowsen Celius, Ludvig Andre Munthe, John Torgils Vaage, Fridtjof Lund-Johansen, Gro Owren Nygaard
doi: https://doi.org/10.1101/2021.10.15.21264977

Data Availability

All data produced in the present study are available upon reasonable request to the authors All data produced in the present work are contained in the manuscript.

Back to top
Posted October 18, 2021.
Download PDF
Data/Code
Email
Efficacy and safety of a third SARS-CoV-2 vaccination in multiple sclerosis vaccine non-responders
Marton König, Hilde Marie Torgauten, Mathias Herstad Øverås, Adity Chopra, Åslaug Rudjord Lorentzen, The Trung Tran, Siri Mjaaland, Ingeborg Sundsvalen Aaberge, Kjell-Morten Myhr, Stig Wergeland, Tone Berge, Hanne Flinstad Harbo, Øivind Fredvik Torkildsen, Trygve Holmøy, Elisabeth Gulowsen Celius, Ludvig Andre Munthe, John Torgils Vaage, Fridtjof Lund-Johansen, Gro Owren Nygaard
medRxiv 2021.10.15.21264977; doi: https://doi.org/10.1101/2021.10.15.21264977
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area